NewAmsterdam Pharma Co N.V. (NAMS): Shares Outstanding

Annual figures by period end, from SEC filings.

114.40M
As of 2025-12-31
117.65M
As of 2026-06-30
+11.9%
3-year compound annual growth
2022-12-31: 81.56M2023-12-31: 82.47M2024-12-31: 108.06M2025-12-31: 114.40M114.40M
2022-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-31114.40M+5.9%2026-02-18, Balance as of period end
2024-12-31108.06M+31.0%2026-02-18, Balance as of period end
2023-12-3182.47M+1.1%2025-02-26, Balance as of period end
2022-12-3181.56Mn/a2024-02-28, Balance as of period end